When we last looked at Lantheus in May, its stock was trading just under $80 a share. As a reminder, Lantheus Holdings, Inc. is a Bedford, Massachusetts based provider of radiopharmaceutical ...
And in light of that, the trends we're seeing at Lantheus Holdings' (NASDAQ:LNTH) look very promising so lets take a look. The end of cancer? These 15 emerging AI stocks are developing tech that ...
CytoSite will lead initial clinical development with Lantheus having an exclusive option to acquire worldwide development and commercialization rights to the radiotracer. BOSTON, March 26 ...
In other Lantheus news, Director James H. Thrall sold 1,000 shares of Lantheus stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $94.76 ...
Lantheus Holdings, Inc. has a 52-week low of $58.16 and a 52-week high of $126.89. The stock has a fifty day moving average of $93.01 and a 200 day moving average of $96.47.
CytoSite will lead initial clinical development with Lantheus having an exclusive option to acquire worldwide development and commercialization rights to the radiotracer. BOSTON, March 26, 2025 ...
And in light of that, the trends we're seeing at Lantheus Holdings' (NASDAQ:LNTH) look very promising so lets take a look. The end of cancer? These 15 emerging AI stocks are developing tech that will ...
The Lantheus Holdings Inc.-Bond has a maturity date of 12/15/2027 and offers a coupon of 2.6250%. The payment of the coupon will take place 2,0 times per biannual on the 15.06.. The Lantheus ...
Lantheus is promising up to $1.8 billion in milestone payments to POINT if the two radiotherapeutics get FDA approval and meet commercial objectives, plus royalties on net sales.
Explore Lantheus Holdings stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LNTH. Root And ZoomInfo Are Among Top 8 Mid-Cap Gainers Last Week (Feb 24-Feb ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results